{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:04:28Z","timestamp":1773299068257,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1023\/a:1024068525763","type":"journal-article","created":{"date-parts":[[2003,9,12]],"date-time":"2003-09-12T21:07:28Z","timestamp":1063400848000},"page":"355-364","source":"Crossref","is-referenced-by-count":58,"title":["HER2 Codon 655 Polymorphism and Risk of Breast Cancer in African Americans and Whites"],"prefix":"10.1007","volume":"79","author":[{"given":"Robert","family":"Millikan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendra","family":"Worley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorna","family":"Biscocho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Geradts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Iacocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Conway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Dressler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5122735_CR1","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1093\/emboj\/19.13.3159","volume":"19","author":"M Olayioye","year":"2000","unstructured":"Olayioye M, Neve R, Lane H, Hines N: The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19: 3159-3167, 2000","journal-title":"EMBO J"},{"key":"5122735_CR2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0889-8588(18)30188-6","volume":"8","author":"K Porter-Jordan","year":"1994","unstructured":"Porter-Jordan K, Lippman M: Overview of the biologic markers of breast cancer. Hematol Oncol Clin North Am 8: 73-100, 1994","journal-title":"Hematol Oncol Clin North Am"},{"key":"5122735_CR3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/erc.0.0080011","volume":"8","author":"N Prenzel","year":"2001","unstructured":"Prenzel N, Rischer O, Streit S, Hart S, Ullrich A: The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocrine-Related Cancer 8: 11-31, 2001","journal-title":"Endocrine-Related Cancer"},{"key":"5122735_CR4","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1093\/nar\/19.19.5452-a","volume":"19","author":"J Papewalis","year":"1991","unstructured":"Papewalis J, Nikitin A, Rajewsky M: G to A polymorphism at amino acid 655 of the human erbB-2\/HER2 gene. Nucl Acids Res 19: 5452, 1991","journal-title":"Nucl Acids Res"},{"key":"5122735_CR5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/jnci\/92.5.412","volume":"92","author":"D Xie","year":"2000","unstructured":"Xie D, Shu X-O, Deng Z, Wen W-Q, Creek K, Dai Q, Gao Y-T, Jin F, Zheng W: Population-based case-control study of HER2 genetic polymorphisms and breast cancer risk. J Natl Cancer Inst 92: 412-417, 2000","journal-title":"J Natl Cancer Inst"},{"key":"5122735_CR6","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/jnci\/93.21.1658","volume":"93","author":"W Zheng","year":"2001","unstructured":"Zheng W, Wen W-Q: Response [letter]. J Natl Cancer Inst 93: 1658-1659, 2001","journal-title":"J Natl Cancer Inst"},{"key":"5122735_CR7","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/jnci\/93.7.558","volume":"93","author":"W Zheng","year":"2001","unstructured":"Zheng W, Kataoka N, Xie D, Young S: Response [letter]. J Natl Cancer Inst 93: 558-559, 2001","journal-title":"J Natl Cancer Inst"},{"key":"5122735_CR8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/jnci\/93.7.557","volume":"93","author":"S Baxter","year":"2001","unstructured":"Baxter S, Campbell I: Re: Population-based case-control study of HER2 genetic polymorphisms and breast cancer risk [letter]. J Natl Cancer Inst 93: 557-558, 2001","journal-title":"J Natl Cancer Inst"},{"key":"5122735_CR9","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/jnci\/93.21.1657","volume":"93","author":"S Wang-Gohrke","year":"2001","unstructured":"Wang-Gohrke S, Chang-Claude J: Re: Population-based case-control study of HER2 genetic polymorphisms and breast cancer risk [letter]. J Natl Cancer Inst 93: 1657-1658, 2001","journal-title":"J Natl Cancer Inst"},{"key":"5122735_CR10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3835(01)00671-1","volume":"173","author":"C Keshava","year":"2001","unstructured":"Keshava C, McCanlies E, Keshava N, Wolff M, Weston A: Distribution of HER2 V655 genotypes in breast cancer cases and controls in the United States. Cancer Letters 173: 37-41, 2001","journal-title":"Cancer Letters"},{"key":"5122735_CR11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00694745","volume":"34","author":"B Newman","year":"1995","unstructured":"Newman B, Moorman P, Millikan R, Qaqish B, Geradts J, Aldrich T, Liu E: The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Research and Treatment 34: 51-60, 1995","journal-title":"Breast Cancer Research and Treatment"},{"key":"5122735_CR12","first-page":"371","volume":"7","author":"R Millikan","year":"1998","unstructured":"Millikan R, Pittman G, Newman B, Rockhill B, Savitz D, Bell D: Cigarette smoking and N-acetyltransferases 1 and 2 and breast cancer. Cancer Epidem Biomark Prev 7: 371-378, 1998","journal-title":"Cancer Epidem Biomark Prev"},{"key":"5122735_CR13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/oxfordjournals.aje.a116104","volume":"134","author":"C Weinberg","year":"1991","unstructured":"Weinberg C, Sandler D: Randomized recruitment in casecontrol studies. Am J Epidem 134: 421-432, 1991","journal-title":"Am J Epidem"},{"key":"5122735_CR14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/A:1006354627669","volume":"58","author":"L Dressler","year":"1999","unstructured":"Dressler L, Geradts J, Burroughs M, Cowan D, Millikan R, Newman B: Policy guidelines for the utilization of formalin-fixed, paraffin-embedded tissue sections: The UNC SPORE experience. Breast Cancer Res Treat 58: 31-39, 1999","journal-title":"Breast Cancer Res Treat"},{"key":"5122735_CR15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1023\/A:1017994726207","volume":"68","author":"H Furberg","year":"2001","unstructured":"Furberg H, Millikan R, Dressler L, Newman B, Geradts J: Tumor characteristics in African American and white women. Breast Cancer Res Treatment 68: 33-43, 2001","journal-title":"Breast Cancer Res Treatment"},{"key":"5122735_CR16","first-page":"65","volume":"9","author":"W-Y Huang","year":"2000","unstructured":"Huang W-Y, Newman B, Millikan R, Conway K, Hulka B, Schell M, Liu E: Risk of breast cancer according to the status of HER2\/neu oncogene amplification. Cancer Epidemiol Biomarkers Prev 9: 65-71, 2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5122735_CR17","unstructured":"Dressler L, Cowan D, Huang W-Y, Tse J, Geradts J, Vick K, Conway K, Edmiston S, Little D, Newman B, Millikan B. Assessment of IHC and PCR to Determine HER2\/neu status in 527 breast cancer specimens: the UNC SPORE Experience. Cancer Research. Proc AACR (Abstract), 2000"},{"key":"5122735_CR18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/oxfordjournals.aje.a009878","volume":"149","author":"D Schaid","year":"1999","unstructured":"Schaid D, Jacobsen S: Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg equilibrium. Am J Epidem 149: 706-711, 1999","journal-title":"Am J Epidem"},{"key":"5122735_CR19","volume-title":"Modern Epidemiology","author":"K Rothman","year":"1998","unstructured":"Rothman K, Greenland S: Modern Epidemiology. 2nd edn. Lippincott-Raven, Philadelphia, 1998","edition":"2nd edn"},{"key":"5122735_CR20","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1093\/jnci\/92.23.1947","volume":"92","author":"M-A Ameyaw","year":"2000","unstructured":"Ameyaw M-A, Thornton N, McLeod H: Re: Population-based case-control study of HER2 genetic polymorphisms and breast cancer risk [letter]. J Natl Cancer Inst 92: 1947, 2000","journal-title":"J Natl Cancer Inst"},{"key":"5122735_CR21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ng853","volume":"31","author":"P Pharoah","year":"2002","unstructured":"Pharoah P, Antoniou A, Bobrow M, Zimmern R, Easton D, Ponder B: Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31: 33-36, 2002","journal-title":"Nat Genet"},{"key":"5122735_CR22","first-page":"1027","volume":"7","author":"E Liu","year":"1992","unstructured":"Liu E, Thor A, He M, Barcos M, Ljung B-M, Benz C: The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene 7: 1027-1032, 1992","journal-title":"Oncogene"},{"key":"5122735_CR23","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/0046-8177(92)90257-4","volume":"23","author":"D Allred","year":"1992","unstructured":"Allred D, Clark G, Molina R, Tandon A, Schnitt S, Gilchrist K, Osborne CK, Tormey D, McGuire W: Overexpression of HER-2\/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum Pathol 23: 974-979, 1992","journal-title":"Hum Pathol"},{"key":"5122735_CR24","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1093\/carcin\/19.11.1943","volume":"19","author":"R Millikan","year":"1998","unstructured":"Millikan R, Pittman G, Duell E, Tse C-K, Moorman P, Newman B, Savitz D: Catechol-O-Methyltransferase (COMT) and breast cancer risk. Carcinogenesis 19: 1943-1947, 1998","journal-title":"Carcinogenesis"},{"key":"5122735_CR25","first-page":"567","volume":"9","author":"R Millikan","year":"2000","unstructured":"Millikan R, Pittman G, Tse C-K, Savitz D, Newman B, Bell D: Glutathione-S-transferases M1, T1 and P1 and breast cancer. Cancer Epidem Biomark Prev 9: 567-573, 2000","journal-title":"Cancer Epidem Biomark Prev"},{"key":"5122735_CR26","first-page":"217","volume":"10","author":"E Duell","year":"2001","unstructured":"Duell E, Millikan R, Pittman G, Winkel S, Lunn R, Tse C-K, Eaton A, Mohrenweiser H, Newman B, Bell D: Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidem Biomark Prev 10: 217-222, 2001","journal-title":"Cancer Epidem Biomark Prev"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1024068525763.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1024068525763\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1024068525763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1024068525763.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T23:23:47Z","timestamp":1750893827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1024068525763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["5122735"],"URL":"https:\/\/doi.org\/10.1023\/a:1024068525763","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}